Adenocarcinoma Of Esophagus Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Adenocarcinoma of Oesophagus / Oesophageal Adenocarcinoma / Adenocarcinoma, Esophageal / Esophageal Adenocarcinomas / Esophageal Adenocarcinoma / Oesophageal adenocarcinoma NOS

IndicationStatusPhase
DBCOND0067383 (Adenocarcinoma Of Esophagus)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04089904Phase II Trial of Neoadjuvant Pembrolizumab for Patients With Early Stage Gastroesophageal AdenocarcinomaTreatment
NCT02998268Study of Pembrolizumab in Locally Advanced Esophageal AdenocarcinomaTreatment